Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
SG&A Expense Growth
2.64%
Quarterly · Period ending:
LCTX SG&A Expense Growth
Latest reported2.64%period ending
Latest reported2.64%period ending
LCTX Quarterly SG&A Growth (QoQ) (0.00% → 2.64%)
Latest values, visible window
High-resolution chart · PNG
LCTX sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 40.3877% | |
| 4.7713% | |
| -4.9146% | |
| -2.2417% | |
| -5.6271% | |
| 19.8588% | |
| -0.8275% | |
| -33.3333% | |
| 20% | |
| 0% | |
| -20% | |
| 25% | |
| 0% | |
| -20% | |
| 25% | |
| 100% | |
| -33.3333% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| -100% | |
| -50% | |
| 0% | |
| 0% | |
| 0% | |
| -33.3333% | |
| 50% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 100% | |
| 0% |